Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031161 · ClinicalTrials.gov registry record · NA
Prevention of Dichloroacetate Toxicity
A NA study of Chronic Disease and Acidosis, Lactic, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00031161: Completed NA study of Chronic Disease and Acidosis, Lactic, sponsored by University of Florida.
NCT00031161 is a NA study of Chronic Disease and Acidosis, Lactic that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00031161, a NA study of Chronic Disease and Acidosis, Lactic, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).
Conditions Studied
Interventions
- DRUG Dichloroacetate
- DRUG Nitisinone (NTBC)
- BEHAVIORAL Low-tyrosin diet
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-09 |
| Phase | NA |
What the finished NCT00031161 record still lists
NCT00031161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 3 interventions - of which Dichloroacetate is the first listed.
NCT00031161 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00031161 about?
NCT00031161 is a clinical study titled "Prevention of Dichloroacetate Toxicity". This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).
What is the current status of trial NCT00031161?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2001-09. Estimated completion is 2005-09.
What conditions does trial NCT00031161 study?
This clinical trial studies the following conditions: Chronic Disease, Acidosis, Lactic.
What interventions are being tested in trial NCT00031161?
The interventions under investigation include: Dichloroacetate (DRUG), Nitisinone (NTBC) (DRUG), Low-tyrosin diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00031161?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00031161 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00031161's enrollment target sits among peer trials
30 43rd of 48 higher than 5 of 48 other Chronic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Click & Pick Study
RECRUITING · NA
-
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
RECRUITING · NA
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia